Livzon Pharmaceutical Group Inc Cash Flow Reinvestment Rate
Livzon Pharmaceutical Group Inc cash flow reinvestment rate. Livzon Pharmaceutical Group Inc (000513) has a Cash Flow Reinvestment Rate of 0.44x as of December 2025, reinvesting CN¥276.99 Million (capex CN¥78.72 Million plus investments CN¥-198.26 Million) from operating cash flow of CN¥625.70 Million. See 000513 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Livzon Pharmaceutical Group Inc (1999–2025)
Cash flow reinvestment rate of Livzon Pharmaceutical Group Inc from 1999 to 2025. Historical reinvestment intensity for Livzon Pharmaceutical Group Inc across 27 annual periods. Explore 000513 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Livzon Pharmaceutical Group Inc Cash Flow Reinvestment Rate by Year (1999–2025)
Livzon Pharmaceutical Group Inc cash flow reinvestment rate by year from 1999 to 2025. Year-by-year capital reinvestment analysis for Livzon Pharmaceutical Group Inc. For the full cash flow conversion analysis, see 000513 cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.60x | CN¥1.90 Billion | CN¥3.18 Billion | CN¥574.14 Million | ▲ +171.0% |
| 2024 | 0.22x | CN¥656.96 Million | CN¥2.98 Billion | CN¥570.16 Million | ▼ -53.1% |
| 2023 | 0.47x | CN¥1.53 Billion | CN¥3.25 Billion | CN¥820.45 Million | ▼ -39.9% |
| 2022 | 0.78x | CN¥2.17 Billion | CN¥2.77 Billion | CN¥940.15 Million | ▼ -25.0% |
| 2021 | 1.04x | CN¥1.98 Billion | CN¥1.90 Billion | CN¥1.31 Billion | ▲ +202.3% |
| 2020 | 0.35x | CN¥745.73 Million | CN¥2.16 Billion | CN¥646.98 Million | ▲ +52.6% |
| 2019 | 0.23x | CN¥399.55 Million | CN¥1.77 Billion | CN¥398.00 Million | ▼ -71.3% |
| 2018 | 0.79x | CN¥997.34 Million | CN¥1.27 Billion | CN¥474.47 Million | ▲ +32.8% |
| 2017 | 0.59x | CN¥779.77 Million | CN¥1.32 Billion | CN¥294.15 Million | ▼ -42.2% |
| 2016 | 1.03x | CN¥1.31 Billion | CN¥1.28 Billion | CN¥368.46 Million | ▲ +70.5% |
| 2015 | 0.60x | CN¥557.97 Million | CN¥927.79 Million | CN¥477.13 Million | ▼ -35.2% |
| 2014 | 0.93x | CN¥665.52 Million | CN¥717.39 Million | CN¥665.52 Million | ▼ -55.6% |
| 2013 | 2.09x | CN¥920.00 Million | CN¥439.99 Million | CN¥920.00 Million | ▲ +62.9% |
| 2012 | 1.28x | CN¥762.30 Million | CN¥593.96 Million | CN¥762.30 Million | ▲ +160.6% |
| 2011 | 0.49x | CN¥348.83 Million | CN¥708.20 Million | CN¥348.83 Million | ▼ -7.4% |
| 2010 | 0.53x | CN¥336.95 Million | CN¥633.30 Million | CN¥336.95 Million | ▲ +100.4% |
| 2009 | 0.27x | CN¥131.41 Million | CN¥494.88 Million | CN¥131.41 Million | ▲ +21.4% |
| 2008 | 0.22x | CN¥75.52 Million | CN¥345.18 Million | CN¥75.52 Million | ▼ -40.4% |
| 2007 | 0.37x | CN¥91.28 Million | CN¥248.55 Million | CN¥91.28 Million | ▼ -53.9% |
| 2006 | 0.80x | CN¥180.45 Million | CN¥226.46 Million | CN¥180.45 Million | ▼ -50.0% |
| 2005 | 1.59x | CN¥256.72 Million | CN¥161.07 Million | CN¥256.72 Million | ▲ +97.4% |
| 2004 | 0.81x | CN¥146.48 Million | CN¥181.46 Million | CN¥146.48 Million | ▲ +133.9% |
| 2003 | 0.35x | CN¥103.56 Million | CN¥300.01 Million | CN¥103.56 Million | ▼ -28.8% |
| 2002 | 0.48x | CN¥103.62 Million | CN¥213.65 Million | CN¥103.62 Million | ▼ -7.7% |
| 2001 | 0.53x | CN¥81.48 Million | CN¥155.15 Million | CN¥81.48 Million | ▼ -67.1% |
| 2000 | 1.60x | CN¥61.49 Million | CN¥38.52 Million | CN¥61.49 Million | ▲ +435.3% |
| 1999 | 0.30x | CN¥73.44 Million | CN¥246.23 Million | CN¥73.44 Million | — |